{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:36:55Z","timestamp":1791895015419,"version":"4.3.4"},"reference-count":71,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Funding for Chinese Medicine Service System and Capacity Building (Key Project with Chinese Medicine Characteristics and Advantages, Ruikang Hospital, 2023"},{"name":"Construction of Clinical Key Specialities in 2023, Urology Department, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine"},{"name":"Guangxi Science and Technology Base and Talent Project\u00c2","award":["AD22035122"],"award-info":[{"award-number":["AD22035122"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3,20]]},"abstract":"<jats:p>\n                    Benign prostatic hyperplasia-related lower urinary tract symptoms are highly prevalent in middle-aged and older men. Compared to traditional transurethral resection of the prostate (TURP), minimally invasive surgical therapies (MISTs) aim to provide meaningful symptom relief. This review evaluated the efficacy, safety, and procedural characteristics of 5 representative MISTs: water vapor thermal therapy (WVTT), prostatic urethral lift (PUL), prostatic artery embolization (PAE), temporary implantable nitinol device (iTIND), and Aquablation. A systematic literature search was conducted in PubMed (2018\u20132023), supplemented by backward citation tracking. Clinical studies reporting International prostate symptom score (IPSS), quality of life (QoL), and\/or maximum flow rate (Qmax) were included, with higher-level evidence prioritized. Long-term data show that WVTT and PUL provide durable symptom improvement, achieving 48% IPSS reduction and 35% IPSS improvement, respectively, at 5 years. Aquablation has a lower rate of retrograde ejaculation than TURP. Importantly, no new sexual dysfunction has been reported after WVTT or PUL. The long-term retrograde ejaculation rate with iTIND is 4%. Most MISTs can be performed in an outpatient setting under local anesthesia. For prostates\u2005&gt;80\u2009cm\n                    <jats:sup>3<\/jats:sup>\n                    , PAE achieved\u2005&gt;44% volume reduction. In summary, MISTs offer personalized treatment options for benign prostatic hyperplasia, though evidence strength varies. Aquablation has the strongest evidence for larger prostates, while WVTT and PUL are guideline-recommended for medium-sized glands. PAE is suitable for older\/high-risk patients, and iTIND shows promise but requires more long-term data. Future research should focus on comparative trials to optimize patient selection.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000047951","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T20:01:56Z","timestamp":1774036916000},"page":"e47951","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Minimally invasive treatments for benign prostatic hyperplasia: A narrative review"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-3457-0545","authenticated-orcid":false,"given":"Xintao","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Graduate School, Guangxi University of Chinese Medicine, Nanning, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisheng","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Ruikang Hospital, Guangxi University of Chinese Medicine, Nanning, Guangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Graduate School, Guangxi University of Chinese Medicine, Nanning, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3594-5880","authenticated-orcid":false,"given":"Hongjun","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Ruikang Hospital, Guangxi University of Chinese Medicine, Nanning, Guangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260422","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/JU.0000000000002183","article-title":"Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE PART I-initial work-up and medical management.","volume":"206","author":"Lerner","year":"2021","journal-title":"J Urol"},{"key":"R2-20260422","doi-asserted-by":"crossref","first-page":"g3861","DOI":"10.1136\/bmj.g3861","article-title":"The management of lower urinary tract symptoms in men.","volume":"348","author":"Rees","year":"2014","journal-title":"BMJ"},{"key":"R3-20260422","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/S0022-5347(01)66780-6","article-title":"Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American urological association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?","volume":"154","author":"Barry","year":"1995","journal-title":"J Urol"},{"key":"R4-20260422","doi-asserted-by":"crossref","first-page":"g4474","DOI":"10.1136\/bmj.g4474","article-title":"Lower urinary tract symptoms in men.","volume":"349","author":"Hollingsworth","year":"2014","journal-title":"BMJ"},{"key":"R5-20260422","doi-asserted-by":"crossref","first-page":"9650","DOI":"10.3390\/ijerph19159650","article-title":"How do patients understand questions about lower urinary tract symptoms? A qualitative study of problems in completing urological questionnaires.","volume":"19","author":"Schlatmann","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"R6-20260422","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1442-2042.1997.tb00138.x","article-title":"Epidemiologic survey of lower urinary tract symptoms in Asia and Australia using the international prostate symptom score.","volume":"4","author":"Homma","year":"1997","journal-title":"Int J Urol"},{"key":"R7-20260422","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/JU.0000000000002184","article-title":"Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE PART II\u2014surgical evaluation and treatment.","volume":"206","author":"Lerner","year":"2021","journal-title":"J Urol"},{"key":"R9-20260422","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.euf.2022.03.012","article-title":"Hot topics of the past decade: evolutions and revolutions in lower urinary tract symptoms.","volume":"8","author":"Cornu","year":"2022","journal-title":"Eur Urol Focus"},{"key":"R10-20260422","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.euf.2022.03.002","article-title":"I can\u2019t get no satisfaction: patient-reported outcomes after different treatment options for lower urinary tract symptoms.","volume":"8","author":"Sze","year":"2022","journal-title":"Eur Urol Focus"},{"issue":"4 Pt 1","key":"R11-20260422","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1097\/01.ju.0000129967.30558.ca","article-title":"Transurethral microwave thermotherapy for benign prostate hyperplasia: separating truth from marketing hype.","volume":"172","author":"Walmsley","year":"2004","journal-title":"J Urol"},{"key":"R12-20260422","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.eururo.2005.12.042","article-title":"Complications of transurethral resection of the prostate (TURP) \u2013 incidence, management, and prevention.","volume":"50","author":"Rassweiler","year":"2006","journal-title":"Eur Urol"},{"key":"R13-20260422","first-page":"CD013656","article-title":"Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis.","volume":"7","author":"Franco","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"R14-20260422","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.eururo.2021.02.008","article-title":"Prostatic artery embolisation versus transurethral resection of the prostate for benign prostatic hyperplasia: 2-yr outcomes of a randomised, open-label, single-centre trial.","volume":"80","author":"Abt","year":"2021","journal-title":"Eur Urol"},{"key":"R15-20260422","first-page":"71","article-title":"Perspective on the Rezum((R)) system: a minimally invasive treatment strategy for benign prostatic hyperplasia using convective radiofrequency water vapor thermal therapy.","volume":"10","author":"Woo","year":"2017","journal-title":"Med Devices (Auckl)"},{"key":"R16-20260422","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/bju.13714","article-title":"Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study.","volume":"119","author":"Gratzke","year":"2017","journal-title":"BJU Int"},{"key":"R17-20260422","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1148\/radiol.2020191249","article-title":"Prostatic artery embolization for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: 10 years\u2019 experience.","volume":"296","author":"Carnevale","year":"2020","journal-title":"Radiology"},{"key":"R18-20260422","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s00270-022-03199-8","article-title":"Long-term outcome of prostatic artery embolization for patients with benign prostatic hyperplasia: single-centre retrospective study in 1072 patients over a 10-year period.","volume":"45","author":"Bilhim","year":"2022","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R19-20260422","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.urology.2020.12.022","article-title":"The iTind temporarily implanted nitinol device for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a multicenter, randomized, controlled trial.","volume":"153","author":"Chughtai","year":"2021","journal-title":"Urology"},{"key":"R20-20260422","first-page":"10960","article-title":"Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPH.","volume":"29","author":"Gilling","year":"2022","journal-title":"Can J Urol"},{"key":"R21-20260422","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.urology.2018.12.041","article-title":"Rez\u016bm water vapor thermal therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia: 4-year results from randomized controlled study.","volume":"126","author":"McVary","year":"2019","journal-title":"Urology"},{"key":"R22-20260422","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.eururo.2023.04.008","article-title":"Summary paper on the 2023 european association of urology guidelines on the management of non-neurogenic male lower urinary tract symptoms.","volume":"84","author":"Gravas","year":"2023","journal-title":"Eur Urol"},{"key":"R23-20260422","first-page":"1509","article-title":"Prostatic artery embolization: indications, preparation, techniques, imaging evaluation, reporting, and complications.","volume":"54","author":"Dias","year":"2021","journal-title":"Radiol Bras"},{"key":"R24-20260422","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/bju.14608","article-title":"Second-generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow-up.","volume":"123","author":"Porpiglia","year":"2019","journal-title":"BJU Int"},{"key":"R25-20260422","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.juro.2017.01.056","article-title":"Aquablation of the prostate for symptomatic benign prostatic hyperplasia: 1-year results.","volume":"197","author":"Gilling","year":"2017","journal-title":"J Urol"},{"key":"R26-20260422","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ucl.2021.07.007","article-title":"New technologies for treatment of benign prostatic hyperplasia.","volume":"49","author":"Elterman","year":"2022","journal-title":"Urol Clin North Am"},{"key":"R27-20260422","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1177\/1756287216671497","article-title":"UroLift: a new minimally-invasive treatment for benign prostatic hyperplasia.","volume":"8","author":"Jones","year":"2016","journal-title":"Ther Adv Urol"},{"key":"R28-20260422","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12894-021-00824-5","article-title":"Prostatic urethral lift (UroLift): a real-world analysis of outcomes using hospital episodes statistics.","volume":"21","author":"Page","year":"2021","journal-title":"BMC Urol"},{"key":"R29-20260422","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00270-016-1516-x","article-title":"Prostatic arterial embolization treating moderate-to-severe lower urinary tract symptoms related to benign prostate hyperplasia: a meta-analysis.","volume":"40","author":"Feng","year":"2017","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"Suppl 3","key":"R30-20260422","first-page":"2","article-title":"Benign prostatic hyperplasia: an update on minimally invasive therapy including aquablation.","volume":"27","author":"Das","year":"2020","journal-title":"Can J Urol"},{"key":"R31-20260422","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/bju.13358","article-title":"Aquablation \u2013 image-guided robot-assisted waterjet ablation of the prostate: initial clinical experience.","volume":"117","author":"Gilling","year":"2016","journal-title":"BJU Int"},{"key":"R32-20260422","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/JU.0000000000001778","article-title":"Final 5-year outcomes of the multicenter randomized sham-controlled trial of a water vapor thermal therapy for treatment of moderate to severe lower urinary tract symptoms secondary to benign prostatic hyperplasia.","volume":"206","author":"McVary","year":"2021","journal-title":"J Urol"},{"key":"R33-20260422","first-page":"8802","article-title":"Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study.","volume":"24","author":"Roehrborn","year":"2017","journal-title":"Can J Urol"},{"key":"R34-20260422","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1089\/end.2022.0226","article-title":"An evaluation of sexual function in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia in men treated with the temporarily implanted nitinol device.","volume":"37","author":"Elterman","year":"2023","journal-title":"J Endourol"},{"key":"R35-20260422","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.eururo.2012.05.028","article-title":"Words of wisdom. Re: prostatic urethral lift: two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia.","volume":"62","author":"Delongchamps","year":"2012","journal-title":"Eur Urol"},{"key":"R36-20260422","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jvir.2017.08.022","article-title":"Efficacy of prostatic artery embolization for catheter-dependent patients with large prostate sizes and high comorbidity scores.","volume":"29","author":"Bhatia","year":"2018","journal-title":"J Vasc Interv Radiol"},{"key":"R37-20260422","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1590\/s1677-5538.ibju.2023.0016","article-title":"Novel minimally invasive treatments for lower urinary tract symptoms: a systematic review and network meta-analysis.","volume":"49","author":"van Kollenburg","year":"2023","journal-title":"Int Braz J Urol"},{"key":"R38-20260422","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.urology.2014.04.028","article-title":"Prostatic artery embolization for prostate volume greater than 80\u2009cm3: results from a single-center prospective study.","volume":"84","author":"Kurbatov","year":"2014","journal-title":"Urology"},{"key":"R39-20260422","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.juro.2017.12.065","article-title":"WATER: a double-blind, randomized, controlled trial of aquablation((R)) vs transurethral resection of the prostate in benign prostatic hyperplasia.","volume":"199","author":"Gilling","year":"2018","journal-title":"J Urol"},{"key":"R40-20260422","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/1756287218793084","article-title":"Rezum: a new transurethral water vapour therapy for benign prostatic hyperplasia.","volume":"10","author":"Westwood","year":"2018","journal-title":"Ther Adv Urol"},{"key":"R41-20260422","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41391-017-0022-9","article-title":"Convective radiofrequency water vapor thermal therapy for benign prostatic hyperplasia: a single office experience.","volume":"21","author":"Mollengarden","year":"2018","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"R42-20260422","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1464-410X.2011.10342.x","article-title":"Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).","volume":"108","author":"Woo","year":"2011","journal-title":"BJU Int"},{"key":"R43-20260422","first-page":"115","article-title":"Benign prostatic hyperplasia and new treatment options \u2013 a critical appraisal of the UroLift system.","volume":"9","author":"McNicholas","year":"2016","journal-title":"Med Devices (Auckl)"},{"key":"R45-20260422","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.urology.2011.10.021","article-title":"Prostatic urethral lift: two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia.","volume":"79","author":"Chin","year":"2012","journal-title":"Urology"},{"key":"R46-20260422","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1743-6109.2011.02568.x","article-title":"Preservation of sexual function with the prostatic urethral lift: a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia.","volume":"9","author":"Woo","year":"2012","journal-title":"J Sex Med"},{"key":"R47-20260422","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.eururo.2023.02.028","article-title":"Minimally invasive treatments for benign prostatic obstruction: a systematic review and network meta-analysis.","volume":"83","author":"Cornu","year":"2023","journal-title":"Eur Urol"},{"key":"R48-20260422","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41391-018-0118-x","article-title":"Prostatic Urethral Lift (PUL) for obstructive median lobes: 12 month results of the MedLift study.","volume":"22","author":"Rukstalis","year":"2019","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"R49-20260422","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S1051-0443(07)61638-8","article-title":"Relief of benign prostatic hyperplasia-related bladder outlet obstruction after transarterial polyvinyl alcohol prostate embolization.","volume":"11","author":"DeMeritt","year":"2000","journal-title":"J Vasc Interv Radiol"},{"key":"R50-20260422","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1148\/radiol.2463070647","article-title":"Benign prostatic hyperplasia: transcatheter arterial embolization as potential treatment--preliminary study in pigs.","volume":"246","author":"Sun","year":"2008","journal-title":"Radiology"},{"key":"R51-20260422","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1053\/j.tvir.2012.09.002","article-title":"How to perform prostatic arterial embolization.","volume":"15","author":"Martins Pisco","year":"2012","journal-title":"Tech Vasc Interv Radiol"},{"key":"R52-20260422","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1007\/s00270-018-1941-0","article-title":"Prostatic artery embolization (PAE) for benign prostatic hyperplasia (BPH) with haematuria in the absence of an upper urinary tract pathology.","volume":"41","author":"Tapping","year":"2018","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R53-20260422","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00270-020-02657-5","article-title":"Systematic review and meta-analysis comparing prostatic artery embolization to gold-standard transurethral resection of the prostate for benign prostatic hyperplasia.","volume":"44","author":"Knight","year":"2021","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R54-20260422","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.euros.2020.05.001","article-title":"A systematic review and meta-analysis of prostatic urethral lift for male lower urinary tract symptoms secondary to benign prostatic hyperplasia.","volume":"19","author":"Xiang","year":"2020","journal-title":"Eur Urol Open Sci"},{"key":"R55-20260422","first-page":"CD012867","article-title":"Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.","volume":"2022","author":"Jung","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"R56-20260422","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1007\/s00330-020-07663-2","article-title":"Efficacy and safety of prostatic artery embolization for benign prostatic hyperplasia: a systematic review and meta-analysis of randomized controlled trials.","volume":"31","author":"Xiang","year":"2021","journal-title":"Eur Radiol"},{"key":"R57-20260422","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/iju.12797","article-title":"Prostatic arterial embolization for the treatment of lower urinary tract symptoms as a result of large benign prostatic hyperplasia: a prospective single-center investigation.","volume":"22","author":"Wang","year":"2015","journal-title":"Int J Urol"},{"key":"R58-20260422","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.jvir.2016.04.001","article-title":"Medium- and long-term outcome of prostate artery embolization for patients with benign prostatic hyperplasia: results in 630 patients.","volume":"27","author":"Pisco","year":"2016","journal-title":"J Vasc Interv Radiol"},{"key":"R59-20260422","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.euf.2022.04.005","article-title":"Prostatic artery embolisation: do we still need it and for whom?","volume":"8","author":"Abt","year":"2022","journal-title":"Eur Urol Focus"},{"key":"R60-20260422","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1007\/s00270-017-1700-7","article-title":"Cost analysis of prostate artery embolization (PAE) and transurethral resection of the prostate (TURP) in the treatment of benign prostatic hyperplasia.","volume":"40","author":"Bagla","year":"2017","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R61-20260422","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41391-020-00281-5","article-title":"3-Year results following treatment with the second generation of the temporary implantable nitinol device in men with LUTS secondary to benign prostatic obstruction.","volume":"24","author":"Amparore","year":"2021","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"R62-20260422","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.euf.2018.04.009","article-title":"What\u2019s new in TIND?","volume":"4","author":"Marcon","year":"2018","journal-title":"Eur Urol Focus"},{"key":"R63-20260422","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/bju.14141","article-title":"3\u2010Year follow-up of temporary implantable nitinol device implantation for the treatment of benign prostatic obstruction.","volume":"122","author":"Porpiglia","year":"2018","journal-title":"BJU Int"},{"key":"R64-20260422","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1007\/s00345-020-03418-2","article-title":"Urinary and sexual function after treatment with temporary implantable nitinol device (iTind) in men with LUTS: 6-month interim results of the MT-06-study.","volume":"39","author":"De Nunzio","year":"2021","journal-title":"World J Urol"},{"key":"R65-20260422","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11934-019-0912-6","article-title":"First- and second-generation temporary implantable nitinol devices as minimally invasive treatments for BPH-Related LUTS: systematic review of the literature.","volume":"20","author":"Amparore","year":"2019","journal-title":"Curr Urol Rep"},{"key":"R66-20260422","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.euf.2021.02.013","article-title":"New endoscopic in-office surgical therapies for benign prostatic hyperplasia: a systematic review.","volume":"8","author":"Tzeng","year":"2022","journal-title":"Eur Urol Focus"},{"key":"R67-20260422","first-page":"8590","article-title":"How I do it: aquablation of the prostate using the AquaBeam system.","volume":"23","author":"Macrae","year":"2016","journal-title":"Can J Urol"},{"key":"R68-20260422","first-page":"10072","article-title":"Three-year outcomes after aquablation therapy compared to TURP: results from a blinded randomized trial.","volume":"27","author":"Gilling","year":"2020","journal-title":"Can J Urol"},{"key":"R69-20260422","first-page":"10610","article-title":"Focal bladder neck cautery associated with low rate of post-aquablation bleeding.","volume":"28","author":"Elterman","year":"2021","journal-title":"Can J Urol"},{"key":"R70-20260422","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.urology.2022.04.004","article-title":"WATER vs WATER II 3-year update: comparing aquablation therapy for benign prostatic hyperplasia in 30-80 cc and 80-150 cc prostates.","volume":"165","author":"Assad","year":"2022","journal-title":"Urology"},{"key":"R71-20260422","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.euf.2022.04.013","article-title":"Expectations facing reality: complication management after aquablation treatment for lower urinary tract symptoms.","volume":"8","author":"Probst","year":"2022","journal-title":"Eur Urol Focus"},{"key":"R72-20260422","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/bju.14990","article-title":"Transfusion rates after 800 aquablation procedures using various haemostasis methods.","volume":"125","author":"Elterman","year":"2020","journal-title":"BJU Int"},{"key":"R73-20260422","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00345-009-0503-0","article-title":"Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction.","volume":"28","author":"Herrmann","year":"2010","journal-title":"World J Urol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047951","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T06:01:53Z","timestamp":1776837713000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":71,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047951","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"assertion":[{"value":"2025-01-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}